The ever-accumulating evidence has demonstrated that Nrf1 is a key player in the pathogenesis of NASH and HCC, as well as other relevant neurodegenerative diseases and type 2 diabetes [32,33]. The gene discussed is NRF1; the disease is metabolic dysfunction-associated steatohepatitis.